Burkholderia cepacia genomovar III and Burkholderia vietnamiensis double infection in a cystic fibrosis child

Journal of Cystic Fibrosis

Volumn 1, Issue 4, 2002, Pages 292-294

  Magalhães, Marcelo ^a   de Britto, Murilo C A ^b   Vandamme, Peter ^c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Burkolderia cepacia complex; Double infection

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; PANCREAS ENZYME; PILOCARPINE; RECA PROTEIN; TRIMETHOPRIM SULFAMETHOXAZOLE COMBINATION; TRYPSIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM CULTURE; BRAZIL; BURKHOLDERIA; BURKHOLDERIA CEPACIA; CASE REPORT; COMORBIDITY; COUGHING; CYSTIC FIBROSIS; DISEASE SEVERITY; GENETICS; HUMAN; INFANT; IONTOPHORESIS; ISOLATION AND PURIFICATION; MALE; MALNUTRITION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIXED INFECTION; PROTEIN ELECTROPHORESIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; THROAT CULTURE; TREATMENT OUTCOME;

EID: 0036900243     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-1993(02)00101-7     Document Type: Article

References (20)

1. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine iontophoresis. Pediatrics 1959;23:545-9.
2. National Center for Health Statistics. Available from: www.cdc.gov/growthcharts/
3. Shwachman H, Kulczycki LL. Long term study of one hundred and five patients with cystic fibrosis. Am. J. Dis. Child 1958;96:6-26.
4. Henry D, Campbell M, McGimpsey C, et al. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J. Clin. Microbiol. 1999;37:1004-7.
5. Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 2001;39:1073-8.
6. Vandamme P, Holmes B, Vancanneyt M, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int. J. Syst. Bacteriol. 1997;47:1188-200.
7. Mahenthiralingam E, Bischof J, Byrne SK, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 2000;38:3165-73.
8. Jorgensen JH, Turnidge JD, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. 7th ed.. Manual of clinical microbiology. Washington, DC: American Society for Microbiology, ASM Press, 1999. p. 1526-46.
9. Isles A, Maclusky I, Corey M, et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J. Pediatr. 1984;104:206-10.
10. Coenye T, Vandamme P, Govan JRW, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 2001;39:3427-36.
11. LiPuma JJ, Spilker T, Gill LH, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissible markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2001;164:92-6.
12. Mahenthiralingam E, Vandamme P, Campbell ME, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace B. multivorans. Clin. Infect. Dis. 2001;33:1469-75.
13. Sun L, Jiang R, Steinbach S, et al. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF center epidemics in North America and Britain. Nat. Med. 1995;1:661-6.
14. Mahenthiralingam E, Simpson D, Speert DP. Identification and characterization of a novel DNA marker associated with cystic fibrosis. J. Clin. Microbiol. 1997;35:808-16.
15. Tran Van V, Mavingui P, Berge O, Balandreau J, Heulin T. Promotion de croissance du riz inoculé par une bactérie fixatrice d'azote, Burkholderia vietnamiensis, isolée d'un sol sulfaté du Viêt-nam. Agronomie 1994;14:697-707.
16. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg. Infect. Dis. 2002;8:181-7.
17. Berriatua E, Ziluaga I, Miguel-Virto C, et al. Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J. Clin. Microbiol. 2001;39:990-4.
18. Van Laer F, Raes D, Vandamme P, et al. An outbreak of Burkholderia cepacia with septicaemia on a cardiology ward. Infect. Control Hosp. Epidemiol. 1998;19:112-3.
19. Chen JS, Whitzmann KA, Spilker T, Fink RJ, LiPuma JJ. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. J. Pediatr. 2001;139:643-9.
20. Ledson MJ, Gallager MJ, Corkill JE, Hart CA, Walshaw MJ. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax 1998;53:432-6.